Search Results - "PRACHAND, Sheila N"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: Enhancement of apoptosis by manipulation of cellular redox state by GARTENHAUS, Ronald B, PRACHAND, Sheila N, PANIAQUA, Mary, LI, Yuyu, GORDON, Leo I

    Published in Clinical cancer research (01-02-2002)
    “…We investigated the ability of pretreatment with buthionine sulfoximine (BSO) to overcome a priori resistance to arsenic trioxide (As(2)O(3)) in multiple…”
    Get full text
    Journal Article
  2. 2

    Motexafin Gadolinium Enhances p53-Mdm2 Interactions, Reducing p53 and Downstream Targets in Lymphoma Cell Lines by SINGH, Amareshwar T. K, EVENS, Andrew M, PRACHAND, Sheila N, GORDON, Leo I

    Published in Anticancer research (01-04-2010)
    “…Loss of p53 renders cells more susceptible to acute oxidant stress induced by oxidant-generating agents such as motexafin gadolinium (MGd). We hypothesized…”
    Get full text
    Journal Article
  3. 3

    Motexafin Gadolinium (MGD) Induces Oxidant Stress and Downregulates Both Pro and Anti-Oxidant Genes in the Ramos Lymphoma Cell Line: Signaling through p53 Mediated Pathways by Singh, Amareshwar T.K., Evens, Andrew M., Haque, Qudsia, Prachand, Sheila N., Singh, Karthik T.K., Gordon, Leo I.

    Published in Blood (16-11-2007)
    “…We have reported that MGd, an expanded porphyrin and redox stress inducer, lowers p53 protein but not message in lymphoma cell lines. These results suggested…”
    Get full text
    Journal Article
  4. 4

    Arsenic Trioxide Cytotoxicity in Steroid and Chemotherapy-resistant Myeloma Cell Lines by Ronald B. Gartenhaus, Sheila N. Prachand, Mary Paniaqua, Yuyu Li, Leo I. Gordon

    Published in Clinical cancer research (01-02-2002)
    “…Purpose: We investigated the ability of pretreatment with buthionine sulfoximine (BSO) to overcome a priori resistance to arsenic trioxide (As 2 O 3 ) in…”
    Get full text
    Journal Article